Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)

China flag China · Delayed Price · Currency is CNY
110.94
+2.59 (2.39%)
At close: Jan 23, 2026
4.15%
Market Cap15.28B
Revenue (ttm)591.28M
Net Income (ttm)180.33M
Shares Out137.75M
EPS (ttm)1.31
PE Ratio84.99
Forward PE81.57
Dividend0.80 (0.72%)
Ex-Dividend DateMay 29, 2025
Volume245,307
Average Volume441,669
Open109.00
Previous Close108.35
Day's Range108.05 - 111.29
52-Week Range95.28 - 132.94
Beta0.27
RSI47.18
Earnings DateApr 22, 2026

About SHA:688198

Beijing Balance Medical Technology Co.,Ltd. engages in the research and development, production, sale, and service of animal-derived implantable medical devices in China. The company offers artificial biological heart valves, bovine pericardial and porcine aortic valves; pulmonary valved conduit; tissue antigen removal processor, annuloplasty and valvuloplasty rings, and surgical biological patches; bovine pericardial valves, as well as pulmonary artery valved pipeline, outflow tract single flap patches, etc. Its products are used in heart valv... [Read more]

Sector Healthcare
Founded 2005
Employees 611
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688198
Full Company Profile

Financial Performance

In 2024, SHA:688198's revenue was 501.88 million, an increase of 35.41% compared to the previous year's 370.64 million. Earnings were 146.33 million, an increase of 27.02%.

Financial Statements